IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$10.6M
3
+$7.73M
4
SAGE
Sage Therapeutics
SAGE
+$6.1M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$5.3M

Top Sells

1
+$12.7M
2
+$11.3M
3
+$11.1M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.76M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-329
102
– –
-7,064
103
– –
-615,856
104
– –
-53,703
105
– –
-38,600
106
– –
-5,953
107
– –
-26,831
108
– –
-225,991
109
– –
-80,000
110
– –
0
111
– –
0
112
– –
0
113
– –
-105,341
114
– –
-70,277
115
– –
0
116
– –
-4,848
117
– –
0
118
– –
0
119
– –
0
120
– –
-40,000
121
– –
-19,002
122
– –
-98,039
123
– –
0
124
– –
-81,843
125
– –
-27
2 3 4
5
6